Is Hologic Stock a Good Investment?
Hologic Investment Advice | HOLX |
- Examine Hologic's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Hologic's leadership team and their track record. Good management can help Hologic navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Hologic's business and its evolving consumer preferences.
- Compare Hologic's performance and market position to its competitors. Analyze how Hologic is positioned in terms of product offerings, innovation, and market share.
- Check if Hologic pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Hologic's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Hologic stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Hologic is a good investment.
Sell | Buy |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Hologic Stock
Researching Hologic's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company shares are owned by institutional investors. The book value of Hologic was currently reported as 21.34. The company has Price/Earnings To Growth (PEG) ratio of 1.28. Hologic had not issued any dividends in recent years. The entity had 2:1 split on the 3rd of April 2008.
To determine if Hologic is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Hologic's research are outlined below:
| Hologic generated a negative expected return over the last 90 days | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: CORRECTION RadNets DeepHealth Subsidiary Expands FDA Clearance for SmartMammo Solution |
Hologic Quarterly Accounts Payable |
|
Hologic uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Hologic. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Hologic's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 1st of February 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of November 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact Hologic's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Hologic's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2006-01-24 | 2005-12-31 | 0.07 | 0.06 | -0.01 | 14 | ||
2005-11-02 | 2005-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2005-04-27 | 2005-03-31 | 0.06 | 0.07 | 0.01 | 16 | ||
2004-11-10 | 2004-09-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2003-11-12 | 2003-09-30 | 0.02 | 0.03 | 0.01 | 50 | ||
2000-08-01 | 2000-06-30 | -0.03 | -0.04 | -0.01 | 33 | ||
1998-07-30 | 1998-06-30 | 0.09 | 0.08 | -0.01 | 11 | ||
1998-02-03 | 1997-12-31 | 0.05 | 0.04 | -0.01 | 20 |
Know Hologic's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Hologic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hologic backward and forwards among themselves. Hologic's institutional investor refers to the entity that pools money to purchase Hologic's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ameriprise Financial Inc | 2024-06-30 | 3.5 M | Amvescap Plc. | 2024-06-30 | 3.4 M | Renaissance Technologies Corp | 2024-09-30 | 2.8 M | Black Creek Investment Management Inc | 2024-09-30 | 2.7 M | Manufacturers Life Insurance Co | 2024-09-30 | 2.6 M | Northern Trust Corp | 2024-09-30 | 2.5 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 2.5 M | Norges Bank | 2024-06-30 | 2.4 M | Bank Of America Corp | 2024-06-30 | 2.4 M | Vanguard Group Inc | 2024-09-30 | 27 M | Blackrock Inc | 2024-06-30 | 23.1 M |
Hologic's market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 18.04 B.Market Cap |
|
Hologic's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.16 | 0.09 | |
| Return On Capital Employed | 0.11 | 0.08 | |
| Return On Assets | 0.09 | 0.05 | |
| Return On Equity | 0.15 | 0.09 |
Determining Hologic's profitability involves analyzing its financial statements and using various financial metrics to determine if Hologic is a good buy. For example, gross profit margin measures Hologic's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Hologic's profitability and make more informed investment decisions.
Hologic's Earnings Breakdown by Geography
Please note, the imprecision that can be found in Hologic's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hologic. Check Hologic's Beneish M Score to see the likelihood of Hologic's management manipulating its earnings.
Evaluate Hologic's management efficiency
Hologic has return on total asset (ROA) of 0.0645 % which means that it generated a profit of $0.0645 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1385 %, meaning that it created $0.1385 on every $100 dollars invested by stockholders. Hologic's management efficiency ratios could be used to measure how well Hologic manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.09 in 2024. Return On Capital Employed is likely to drop to 0.08 in 2024. At this time, Hologic's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 4 B in 2024, whereas Non Current Assets Total are likely to drop slightly above 3.1 B in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 21.76 | 20.33 | |
| Tangible Book Value Per Share | 3.57 | 3.43 | |
| Enterprise Value Over EBITDA | 14.99 | 15.51 | |
| Price Book Value Ratio | 3.71 | 3.41 | |
| Enterprise Value Multiple | 14.99 | 15.51 | |
| Price Fair Value | 3.71 | 3.41 | |
| Enterprise Value | 1.9 B | 2 B |
The decision-making processes within Hologic are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Beta 0.986 |
Basic technical analysis of Hologic Stock
As of the 30th of November, Hologic retains the Standard Deviation of 1.24, market risk adjusted performance of (0.06), and insignificant Risk Adjusted Performance. Hologic technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Hologic's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hologic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hologic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Hologic insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jan Verstreken over two weeks ago Disposition of 601 shares by Jan Verstreken of Hologic at 79.29 subject to Rule 16b-3 | ||
Erik Anderson over two weeks ago Acquisition by Erik Anderson of 14023 shares of Hologic at 79. subject to Rule 16b-3 | ||
Stamoulis Christiana over three months ago Acquisition by Stamoulis Christiana of 90 shares of Hologic at 26.74 subject to Rule 16b-3 | ||
Brandon Schnittker over three months ago Disposition of 476 shares by Brandon Schnittker of Hologic at 83.108 subject to Rule 16b-3 | ||
Peter Dunne over three months ago Disposition of 5014 shares by Peter Dunne of Hologic at 71.94 subject to Rule 16b-3 | ||
Stephen MacMillan over six months ago Disposition of 12000 shares by Stephen MacMillan of Hologic subject to Rule 16b-3 | ||
Scott Garrett over six months ago Disposition of 90 shares by Scott Garrett of Hologic at 26.74 subject to Rule 16b-3 |
Hologic's Outstanding Corporate Bonds
Hologic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hologic uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hologic bonds can be classified according to their maturity, which is the date when Hologic has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| Hologic 4625 percent Corp BondUS436440AM32 | View | |
| HOLOGIC INC 325 Corp BondUS436440AP62 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Understand Hologic's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Hologic's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 0.8884 | |||
| Coefficient Of Variation | (13,723) | |||
| Standard Deviation | 1.24 | |||
| Variance | 1.53 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 8.14 | |||
| Value At Risk | (1.79) | |||
| Potential Upside | 1.81 | |||
| Skewness | (1.57) | |||
| Kurtosis | 6.66 |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 0.8884 | |||
| Coefficient Of Variation | (13,723) | |||
| Standard Deviation | 1.24 | |||
| Variance | 1.53 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 8.14 | |||
| Value At Risk | (1.79) | |||
| Potential Upside | 1.81 | |||
| Skewness | (1.57) | |||
| Kurtosis | 6.66 |
Consider Hologic's intraday indicators
Hologic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Hologic stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Hologic Corporate Filings
10K | 27th of November 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
F4 | 18th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 8th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Hologic Stock media impact
Far too much social signal, news, headlines, and media speculation about Hologic that are available to investors today. That information is available publicly through Hologic media outlets and privately through word of mouth or via Hologic internal channels. However, regardless of the origin, that massive amount of Hologic data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Hologic news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Hologic relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Hologic's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Hologic alpha.
Hologic Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Hologic can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Hologic Historical Investor Sentiment
Investor biases related to Hologic's public news can be used to forecast risks associated with an investment in Hologic. The trend in average sentiment can be used to explain how an investor holding Hologic can time the market purely based on public headlines and social activities around Hologic. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Hologic's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Hologic and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Hologic news discussions. The higher the estimate score, the more favorable the investor's outlook on Hologic.
Hologic Corporate Management
| Mark Irving | VP Secretary | Profile | |
| Paul Malenchini | Chief Officer | Profile | |
| Peter Dunne | Senior Resources | Profile | |
| Benjamin Cohn | Principal Chief Accounting Officer | Profile | |
| Erik Anderson | Division Solutions | Profile | |
| Kevin Thornal | Group Solutions | Profile |
Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.